NCT07385911

Brief Summary

Olfaction is a prominent entity that determines a person's quality of life. During human evolution, olfaction has played an essential role in determining safe food, assessing threats, and developing social relationships. Endoscopic endonasal surgeries are widely used today for the removal of brain tumors involving the pituitary and skull base. The minimal invasiveness, rapid recovery, better visualization, and lower occurrence of complication make endonasal endoscopic surgery an ideal approach for tumors involving the pituitary and midline skull base. However, the olfactory epithelium is at risk of injury during endoscopic skull base surgeries due to the orientation of the olfactory epithelium fibers.It has been found that the olfactory neuroepithelium extends from the cribriform plate superiorly to the septum for the superior-most 1 to 2 cm medially and onto the upper half of the superior turbinates laterally.It also extends from the face of the sphenoid posteriorly to the attachment of the middle turbinate anteriorly.This makes the olfactory fibers susceptible to injury during endonasal surgery that requires superior or upper limb septal incisions, such as the pedicled nasoseptal flap (the Hadad-Bassagasteguy flap) and modified nasoseptal rescue flap.It has been debated whether using a scalpel instead of cautery could have a differential effect on the olfaction of an individual, as some surgeons believe that the heat generated by a cautery injures the nearby olfactory mucosa.This study aims at determining the method which is better at preserving the olfactory capacity of an individual undergoing endoscopic endonasal skull base surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
May 2025Aug 2026

Study Start

First participant enrolled

May 18, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

February 4, 2026

Status Verified

January 1, 2026

Enrollment Period

1.3 years

First QC Date

December 18, 2025

Last Update Submit

January 27, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Combined Olfactory Score (I-smell test)

    Threshold odour identification score and specific odour identification score will be added to form a Combined Olfactory Score.

    Preoperatively,Immediate postoperatively,3-6 months postoperatively

  • Visual Analogue Scale (VAS)

    Visual analogue scale scoring from 0-10 to measure olfaction. (with higher score indicating better olfaction capacity)

    Preoperatively,Immediately postoperatively,3-6 months postoperatively

Secondary Outcomes (1)

  • 22-item Sino Nasal Outcome Test (SNOT-22) questionnaire

    Preoperatively,Immediate postoperatively,3-6 months postoperatively

Study Arms (2)

Group A

EXPERIMENTAL

During endoscopic endonasal skull base surgery,scalpel will be used to elevate the nasoseptal flap.

Procedure: Scalpel

Group B

ACTIVE COMPARATOR

During endoscopic endonasal skull base surgery,cautery will be used to elevate the nasoseptal flap.

Procedure: Cautery

Interventions

ScalpelPROCEDURE

During endoscopic endonasal skull base surgery,scalpel will be used to elevate the nasoseptal flap.

Group A
CauteryPROCEDURE

During endoscopic endonasal skull base surgery,cautery will be used to elevate the nasoseptal flap.

Group B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing endoscopic endonasal skull base surgeries that require the raising of a nasoseptal flap

You may not qualify if:

  • Patients with preoperative anosmia due to any cause.
  • Patients with a previous history of sino-nasal, pituitary, or skull base surgery.
  • Patients with a medical history of neurodegenerative diseases (for example, Alzheimer's disease or Parkinson's disease), chronic rhinosinusitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All India Institute Of Medical Sciences

Jodhpur, Rajasthan, 342005, India

RECRUITING

Related Publications (3)

  • Kim SW, Park KB, Khalmuratova R, Lee HK, Jeon SY, Kim DW. Clinical and histologic studies of olfactory outcomes after nasoseptal flap harvesting. Laryngoscope. 2013 Jul;123(7):1602-6. doi: 10.1002/lary.24107. Epub 2013 Mar 21.

  • Puccinelli CL, Yin LX, O'Brien EK, Van Gompel JJ, Choby GW, Van Abel KM, Janus JR, Stokken JK. Long-term olfaction outcomes in transnasal endoscopic skull-base surgery: a prospective cohort study comparing electrocautery and cold knife upper septal limb incision techniques. Int Forum Allergy Rhinol. 2019 May;9(5):493-500. doi: 10.1002/alr.22291. Epub 2019 Jan 18.

  • Hong SD, Nam DH, Park J, Kim HY, Chung SK, Dhong HJ. Olfactory outcomes after endoscopic pituitary surgery with nasoseptal "rescue" flaps: electrocautery versus cold knife. Am J Rhinol Allergy. 2014 Nov-Dec;28(6):517-9. doi: 10.2500/ajra.2014.28.4109.

MeSH Terms

Conditions

Anosmia

Interventions

Laser TherapyCautery

Condition Hierarchy (Ancestors)

Olfaction DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Central Study Contacts

Ananya Srivastava, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2025

First Posted

February 4, 2026

Study Start

May 18, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

February 4, 2026

Record last verified: 2026-01

Locations